Patent
Immunogenic complexes and methods relating thereto
John Cooper Cox,Debbie Drane,Andreas Suhrbier +2 more
- 17 Feb 2000
29
TL;DR: In this paper, an immunogenic complex consisting of a charged organic carrier and a charged antigen was proposed for facilitating the induction of a cytotoxic T-lymphocyte response to an antigen.
read more
Abstract: The present invention relates generally to an immunogenic complex comprising a charged organic carrier and a charged antigen and, more particularly, a negatively charged organic carrier and a positively charged antigen The complexes of the present invention are useful, inter alia, as therapeutic and/or prophylactic agents for facilitating the induction of a cytotoxic T-lymphocyte response to an antigen
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Antigenic tau peptides and uses thereof
George J. Smith,Wills Kenneth Nelson,Jeff Xianchao Zhu +2 more
- 20 Jul 2010
TL;DR: The present disclosure relates to immunogens and compositions comprising an antigenic tau peptide, preferably linked to an immunogenic carrier for use in the treatment of tau-related neurological disorders as discussed by the authors.
25
Patent
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
David A. Cooper,Emilio A. Emini,Jianxin Gu,Mingming Han,Kathrin U. Jansen,Rajesh Kumar Kainthan,Jin-Hwan Kim,Avvari Krishna Prasad,Michael W. Pride,Wendy Watson,Yang Yu-Ying +10 more
- 15 Jan 2015
TL;DR: In this paper, the authors proposed new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof.
24
Patent
Pneumococcal vaccine and uses thereof
Heather L. Davis,Arthur M. Krieg,Lohse Nicolai,Lars Ostergaard,Henrik Carl Schønheyder,Ole Schmeltz Søgaard +5 more
- 17 Mar 2010
TL;DR: The present invention relates to new pneumococcal vaccines and also relates to vaccination of subjects, in particular immunocompromised subjects, against pneumoccocal infections using said novel pneumoccal vaccines as mentioned in this paper.
21
Patent
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
Charlotte A. Kensil
- 20 Dec 2002
TL;DR: In this article, the authors present pharmaceutical compositions that are useful for the prevention and treatment of infectious diseases, primary and metastatic neoplastic diseases (i.e., cancer), neurodegenerative or amyloid diseases, or any other disease wherein the treatment of such disease would be improved by an enhanced immune response.
20
Patent
Methods and compositions for inducing antigen-specific immune responses
Heather L. Davis,Michael J. McCluskie,Deborah P. Drane +2 more
- 18 Jul 2005
TL;DR: In this article, the authors showed that both oligonucleotides containing immune stimulatory motifs and lacking immune stimulating motifs contribute to an interferon-gamma response when administered with an immune stimulating complex.
19
References
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
TL;DR: This assay is very reproducible and rapid with the dye binding process virtually complete in approximately 2 min with good color stability for 1 hr with little or no interference from cations such as sodium or potassium nor from carbohydrates such as sucrose.
254.4K
Cpg motifs in bacterial dna trigger direct b-cell activation
Arthur M. Krieg,Ae-Kyung Yi,Sara Matson,Thomas J. Waldschmidt,Gail A. Bishop,Gail A. Bishop,Rebecca M. Teasdale,Gary A. Koretzky,Dennis M. Klinman +8 more
TL;DR: The potent immune activation by CpG oligon nucleotides has impli-cations for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
3.9K
New methods of drug delivery.
TL;DR: Conventional forms of drug administration generally rely on pills, eye drops, ointments, and intravenous solutions, but a number of novel drug delivery approaches have been developed, which may revolutionize the way many drugs are delivered.
2.4K
•Book
Oligonucleotides and analogues : a practical approach
Fritz Eckstein
- 01 Jan 1991
TL;DR: The present work presents modern machine-aided methods of oligodeoxyribonucleotide synthesis with a focus on the synthesis of oligonucleotides attached to intercalators, photoreactive agents and cleavage agents.
1.1K
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.
TL;DR: A highly T-lymphotropic virus was isolated from cats in a cattery in which all the animals were seronegative for feline leukemia virus, and appears to be antigenically distinct from human immunodeficiency virus.
1K
Related Papers (5)
Nathalie Garçon,Patricia Marie Momin +1 more
- 02 Sep 1998
Thierry Boon,S Silla,Catherine Uyttenhove +2 more
- 09 Jun 1998